Egnite Obtains Patent For NLP MR Classification
Egnite announced issuance of U.S. Patent No. 12,580,057 on April 6, 2026 for an NLP-based system that classifies mitral regurgitation mechanisms from echocardiogram reports. The algorithm, validated on a subset of 5.5 million deidentified reports with 97.3% (maximal) and 99.0% (minimal) accuracy, is deployed across over 600 U.S. healthcare facilities, enabling scalable patient identification for timely interventions.
Scoring Rationale
Official U.S. patent and large-scale validation boost credibility and relevance to clinical NLP; scope is sectoral (cardiology) and the result is actionable for health systems. Score reduced modestly for limited technical disclosure in the release.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Sources
- Read Originalegnite, Inc. Receives U.S. Patent for NLP-Based Algorithm That Classifies Mitral Regurgitation Mechanism from Echocardiographic Reportsprweb.com
